Takeda Pharmaceuticals
Large scale imputation of drug discovery data using deep learning.
Discover how Cerella handled 700,000 compounds and 1,000 experimental endpoints for Takeda Pharmaceuticals.
Genentech
Optimising kinase profiling programmes with deep learning.
See how Cerella could transform Genentech’s kinase programmes, resulting in a 76% reduction in the number of assays required.
Constellation Pharmaceuticals
Practical applications of deep learning to imputation of drug discovery data.
Hear how Constellation Pharmaceuticals saved “two months’ worth of 12 chemists’ workloads” by identifying inactive compounds.
AstraZeneca
Predicting pharmacokinetics parameters and curves.
See how Cerella translated in vitro data into in vivo savings for AstraZeneca.
MSD
Deep learning imputation for peptide bioactivity and property prediction.
Explore how deep learning has transformed the accuracy of predicting bioactivities and other properties for MSD, and how the results can be used to guide experimental prioritisation.
adMare Bioinnovations
Supporting Canadian chemistry pioneers with fast SAR analysis.
“I think StarDrop is a fantastic tool to have as a medicinal chemist, whether you do early-stage medicinal chemistry or deal with a huge amount of data.”
Medicinal chemist, Sébastien Alazet
Open Source Malaria
StarDrop’s Nova identifies a compound that no chemist would have considered.
By using StarDrop’s Nova module to generate new compound ideas, and prioritise those which were most likely to be active, we were able to pinpoint a new anti-malarial molecule which was the only compound to be experimentally proven as active, in an Open Source Malaria competition. None of the project chemists would have considered this compound – they thought it would be inactive, so this opened new avenues for optimisation in the chemical series.
Book a demo with one of our scientists
Discover how Optibrium’s comprehensive in silico platform can boost the speed, efficiency, and productivity of your chemistry discovery programmes.
Five of the world’s top ten pharma and biotech companies trust Optibrium to power their discovery workflows.
